BIOCON

Biocon Ltd. is an India-based global biopharmaceutical company operating in the biotechnology and biopharmaceutical industries. The company focuses on developing and manufacturing affordable therapies for chronic diseases such as diabetes, oncology, and immunology. It operates through four main business segments: Generics, Biosimilars via its subsidiary Biocon Biologics, Research Services through its subsidiary Syngene, and Novel Biologics. Biocon employs a vertically integrated model managing the entire value chain from discovery to commercialization. Its products and services include biotechnology product manufacturing and research services. The company serves customers in over 120 countries worldwide.